Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Evidence for J/ψ Suppression in Incoherent Photonuclear Production.
Physical review letters·2026
Long-Range Transverse-Momentum Correlations and Radial Flow in Pb-Pb Collisions at the LHC.
Physical review letters·2026
First Measurement of A=4 Hypernuclei and Antihypernuclei at the LHC.
Physical review letters·2025
Probing Strangeness Hadronization with Event-by-Event Production of Multistrange Hadrons.
Physical review letters·2025
Measurements of Chemical Potentials in Pb-Pb Collisions at sqrt[s_{NN}]=5.02 TeV.
Physical review letters·2024
Epidemiological evaluation by rRNA-DNA hybridization of strains of Salmonella enterica subsp. enterica serovar Abortusovis isolated in southern Italy in the years 1981-1989.
Bollettino dell'Istituto sieroterapico milanese·1991
Chlamydia trachomatis infection in "sine causa" recurrent abortion.
Bollettino dell'Istituto sieroterapico milanese·1991
[Levels of interleukin-4 (IL-4) in lymphocyte cultures of subjects with HIV-1 infection].
Bollettino dell'Istituto sieroterapico milanese·1991
HTLV-I and HIV-I antibody frequency in thalassemics and drug addicts in southeast Sicily.
Bollettino dell'Istituto sieroterapico milanese·1991
Fluconazole resistance of Candida krusei.
Bollettino dell'Istituto sieroterapico milanese·1991
[Urinary tract infection in an ambulatory population: epidemiological analysis of the etiology and antibiotic resistance of isolated gram-negative strains].
Bollettino dell'Istituto sieroterapico milanese·1991
[Risk Factors for Idiopathic Membranous Nephropathy Complicated by Acute Kidney Injury].
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition·2026
Efficacy and safety of Nefecon, glucocorticoids, or supportive therapyadded to RASi+SGLT2i in IgA nephropathy.
Frontiers in pharmacology·2026
Gaps and disparities in Lp(a) testing before universal screening: A 10-year analysis.
International journal of cardiology. Cardiovascular risk and prevention·2026